Discovery of Cellular Mechanisms Could Open Door to More Effective Anti-Aging Therapies
BioMarin Pharmaceutical Inc, a global biotechnology company announced that the New England Journal of Medicine (NEJM) published an independently peer-reviewed article on up to three years of data from an ongoing phase 1/2 study to evaluate safety and efficacy of investigational AAV gene therapy, valoctocogene roxaparvovec, for severe hemophilia A. This is the second article published by the NEJM on valoctocogene roxaparvovec.
Researchers from the University of Copenhagen have succeeded in extracting a complete human genome from a thousands-of-years old “chewing gum”. According to the researchers, it is a new untapped source of ancient DNA.
A pilot study identified tumors with 100% accuracy
Researchers at the University of Illinois at Urbana-Champaign have successfully used stem cells to engineer living biohybrid nerve tissue to develop 3D models of neural networks with the hopes of gaining a better understanding of how the brain and these networks work.